Top Menu

Archive | Ehrlich on Creative

Bob Ehrlich

DTC for Two Different Drugs in One Ad

Bristol Myers Squibb (BMS) has premiered a very interesting combo DTC ad featuring its two immunotherapy drugs Opdivo and Yervoy. The ad is for treatment of Non Small Cell Lung Cancer (NSCLC). What is very interesting is the approach of advertising two drugs in one ad. The FDA approved the combo for first line treatment […]

Continue Reading 0
Bob Ehrlich

The Vaccines of Glaxo

This is a big year for vaccines. The daily mentions of the progress on Covid-19 vaccine development and the push for increased flu vaccine coverage is raising the awareness of vaccines in general. The push from vaccine makers for their existing vaccines is likely to increase this year.Certainly flu DTC is going to increase as […]

Continue Reading 0
Bob Ehrlich

AbbVie’s Ubrelvy Adds Serena

In my June 24th column I discussed the Ubrelvy campaign. They had a pool of everyday situations at home or work at all times of the day. The “Anytime Anywhere” medicine is the positioning. Coinciding with the start of the US Open tennis tournament, Ubrelvy has engaged Serena Williams to be a spokesperson.Debuting a television ad with […]

Continue Reading 0
Bob Ehrlich

Multiple Sclerosis – A Competitive DTC Category

The multiple sclerosis (MS) category is increasing its DTC use. Historically, low incidence diseases have used print and digital targeted efforts rather than mass. That has changed over the last few years as drugs for Hep C, HIV, lung cancer, and other lower incidence categories have gone mass media including television.Approximately 1 million Americans have […]

Continue Reading 0
Bob Ehrlich

It’s On-Amgen on Health Disparities

Covid-19 has raised a major societal issue on health disparities in America. In many diseases, minority populations suffer more and get less treatment. This is not a new finding, but Covid-19 along with the Black Lives Matter protests on discrimination have given rise to new possibilities of addressing health disparities.Is this the time that health […]

Continue Reading 0
Bob Ehrlich

My Favorite Fowl

Hmm, Aflac or Chantix. Duck or Turkey. What a feast! I have written about the Chantix Turkey when it launched. I liked it then and like it now. I said then that I did not see the use of the turkey as a long term campaign. Apologies to Pfizer and their agency VMLY&R. They have […]

Continue Reading 0
Bob Ehrlich

Xiidra and Their Critter

Sometimes an Rx Drug is also competing with many OTC alternatives. In that case, their DTC ad frequently is more OTC-like than most typical DTC ads. Xiidra is a perfect example of the near OTC ad. It treats dry eye and is the only FDA approved treatment specifically indicated for the signs and symptoms of […]

Continue Reading 0
Bob Ehrlich

Flu Season

One of the most timely and fascinating areas of DTC will be for flu this year. Usually flu advertising is limited in timing and spending. This upcoming season, when America will be dealing with Covid-19 and the flu concurrently, flu advertising has some new opportunities and challenges.As we hear regularly from Dr. Fauci, the combination […]

Continue Reading 0